3 trends in biotech to watch in 2020 – STAT
Here are three trends to watch in biotech in 2020, a year that looks to be laden with opportunities and stumbling blocks for the drug industry.
Here are three trends to watch in biotech in 2020, a year that looks to be laden with opportunities and stumbling blocks for the drug industry.
STAT’s podcast The Readout Loud discusses Summit’s cancer immunotherapy, the company’s co-CEO, Moderna’s spending cuts and weight loss drugs for kids.
Published in BMJ Open Sport and Exercise, the study looked at athletes with spinal cord injuries to better understand neuropathic pain.
Today’s biotech news update includes: • Sarepta’s curselike effect on Robert Califf • AbbVie’s “misleading” TV ad, per the FDA • Moderna spending cuts Get the…
Hospitals could benefit from Vice President Harris’ plan to cancel medical debt. Sign up for STAT’s twice-weekly newsletter about the politics and policy of health…
Advocates for people with rare diseases say a government voucher program has been crucial to pursuing treatments. That program is due to sunset at the…
After being criticized for profligate post-pandemic spending, the company is “pacing” itself to focus on launches of key medicines.
AirPods Pro earbuds will soon double as hearing aids for people with mild to moderate hearing loss.
Gilead said Thursday that its twice-yearly antiviral reduced the risk of HIV infections by 96% compared to an expected rate of infection in a second
The STAT Summit is back in Boston October 16 & 17, 2024 — this year we’re examining change in medicine, why it’s so hard, &…
The 2024 STAT Summit agenda features high-profile panelists discussing topics ranging from drug development to courting biotech investors. Come join us!